Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.15
BSPM's Cash-to-Debt is ranked lower than
86% of the 827 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.89 vs. BSPM: 0.15 )
Ranked among companies with meaningful Cash-to-Debt only.
BSPM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 4.4 Max: No Debt
Current: 0.15
Debt-to-Equity 0.07
BSPM's Debt-to-Equity is ranked higher than
81% of the 535 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 0.30 vs. BSPM: 0.07 )
Ranked among companies with meaningful Debt-to-Equity only.
BSPM' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01  Med: 0.05 Max: 0.08
Current: 0.07
0.01
0.08
Debt-to-EBITDA 0.50
BSPM's Debt-to-EBITDA is ranked lower than
99.99% of the 503 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.74 vs. BSPM: 0.50 )
Ranked among companies with meaningful Debt-to-EBITDA only.
BSPM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.37  Med: -0.05 Max: 0.65
Current: 0.5
-1.37
0.65
Interest Coverage 13.86
BSPM's Interest Coverage is ranked lower than
99.99% of the 641 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 106.84 vs. BSPM: 13.86 )
Ranked among companies with meaningful Interest Coverage only.
BSPM' s Interest Coverage Range Over the Past 10 Years
Min: 1.38  Med: 310.84 Max: No Debt
Current: 13.86
Piotroski F-Score: 5
Altman Z-Score: 0.56
Beneish M-Score: -8.21
WACC vs ROIC
7.05%
0.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % 289.30
BSPM's Operating Margin % is ranked lower than
89% of the 781 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 7.94 vs. BSPM: 289.30 )
Ranked among companies with meaningful Operating Margin % only.
BSPM' s Operating Margin % Range Over the Past 10 Years
Min: -149.5  Med: 10.36 Max: 289.3
Current: 289.3
-149.5
289.3
Net Margin % 97.09
BSPM's Net Margin % is ranked lower than
90% of the 780 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 6.12 vs. BSPM: 97.09 )
Ranked among companies with meaningful Net Margin % only.
BSPM' s Net Margin % Range Over the Past 10 Years
Min: -239.01  Med: 10.57 Max: 97.09
Current: 97.09
-239.01
97.09
ROE % 2.62
BSPM's ROE % is ranked lower than
78% of the 803 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 7.08 vs. BSPM: 2.62 )
Ranked among companies with meaningful ROE % only.
BSPM' s ROE % Range Over the Past 10 Years
Min: -43.08  Med: 12.48 Max: 34.28
Current: 2.62
-43.08
34.28
ROA % 2.26
BSPM's ROA % is ranked lower than
79% of the 831 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 3.77 vs. BSPM: 2.26 )
Ranked among companies with meaningful ROA % only.
BSPM' s ROA % Range Over the Past 10 Years
Min: -37.87  Med: 11.32 Max: 30.2
Current: 2.26
-37.87
30.2
ROC (Joel Greenblatt) % 48.68
BSPM's ROC (Joel Greenblatt) % is ranked lower than
78% of the 817 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 13.08 vs. BSPM: 48.68 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
BSPM' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -74.36  Med: 29.36 Max: 96.91
Current: 48.68
-74.36
96.91
3-Year Revenue Growth Rate -68.10
BSPM's 3-Year Revenue Growth Rate is ranked lower than
98% of the 674 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 5.40 vs. BSPM: -68.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
BSPM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -68.1  Med: -19.4 Max: 56.5
Current: -68.1
-68.1
56.5
GuruFocus has detected 4 Warning Signs with Biostar Pharmaceuticals Inc BSPM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» BSPM's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

BSPM Guru Trades in Q4 2015

Jim Simons 707,370 sh (-85.47%)
» More
Q1 2016

BSPM Guru Trades in Q1 2016

Jim Simons 104,856 sh (+3.76%)
» More
Q2 2016

BSPM Guru Trades in Q2 2016

Jim Simons 105,956 sh (+1.05%)
» More
Q3 2016

BSPM Guru Trades in Q3 2016

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with BSPM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Major    NAICS: 325412    SIC: 2834
Compare:OTCPK:AOXG, OTCPK:INBP, ASX:ANP, SGX:BFK, BOM:530317, BOM:530233, BOM:531173, BOM:530207, LSE:N4P, BOM:523620, BOM:524752, BOM:530057, BOM:524828, BOM:524654, BOM:506919, BOM:524636, BOM:531210, BOM:532989, AMEX:CPHI, BOM:524400 » details
Traded in other countries:7BNB.Germany,
Headquarter Location:China
Biostar Pharmaceuticals Inc, through its subsidiaries is engaged in the business of developing, manufacturing and marketing over-the-counter and prescription pharmaceutical products in the Peoples Republic of China.

Biostar Pharmaceuticals Inc, through its subsidiaries is engaged in the business of developing, manufacturing and marketing over-the-counter and prescription pharmaceutical products in the Peoples Republic of China.

Ratios

vs
industry
vs
history
PE Ratio 2.68
BSPM's PE Ratio is ranked lower than
99.99% of the 570 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 25.41 vs. BSPM: 2.68 )
Ranked among companies with meaningful PE Ratio only.
BSPM' s PE Ratio Range Over the Past 10 Years
Min: 1  Med: 6.46 Max: 84.5
Current: 2.68
1
84.5
PE Ratio without NRI 2.68
BSPM's PE Ratio without NRI is ranked lower than
99.99% of the 566 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 25.56 vs. BSPM: 2.68 )
Ranked among companies with meaningful PE Ratio without NRI only.
BSPM' s PE Ratio without NRI Range Over the Past 10 Years
Min: 1  Med: 6.46 Max: 84.5
Current: 2.68
1
84.5
Price-to-Owner-Earnings 0.37
BSPM's Price-to-Owner-Earnings is ranked higher than
97% of the 310 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 33.43 vs. BSPM: 0.37 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
BSPM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 0.26  Med: 3.72 Max: 392.26
Current: 0.37
0.26
392.26
PB Ratio 0.13
BSPM's PB Ratio is ranked higher than
100% of the 798 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.86 vs. BSPM: 0.13 )
Ranked among companies with meaningful PB Ratio only.
BSPM' s PB Ratio Range Over the Past 10 Years
Min: 0.06  Med: 0.26 Max: 3.22
Current: 0.13
0.06
3.22
PS Ratio 14.68
BSPM's PS Ratio is ranked higher than
64% of the 756 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.79 vs. BSPM: 14.68 )
Ranked among companies with meaningful PS Ratio only.
BSPM' s PS Ratio Range Over the Past 10 Years
Min: 0.13  Med: 0.39 Max: 15.81
Current: 14.68
0.13
15.81
Price-to-Free-Cash-Flow 0.55
BSPM's Price-to-Free-Cash-Flow is ranked higher than
99% of the 212 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 25.72 vs. BSPM: 0.55 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
BSPM' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.37  Med: 2.74 Max: 70
Current: 0.55
0.37
70
Price-to-Operating-Cash-Flow 0.55
BSPM's Price-to-Operating-Cash-Flow is ranked higher than
99% of the 290 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 17.64 vs. BSPM: 0.55 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
BSPM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.37  Med: 2.73 Max: 1793.75
Current: 0.55
0.37
1793.75
EV-to-EBIT 1.81
BSPM's EV-to-EBIT is ranked lower than
99.99% of the 572 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 19.28 vs. BSPM: 1.81 )
Ranked among companies with meaningful EV-to-EBIT only.
BSPM' s EV-to-EBIT Range Over the Past 10 Years
Min: -16.1  Med: 1.8 Max: 58
Current: 1.81
-16.1
58
EV-to-EBITDA 1.40
BSPM's EV-to-EBITDA is ranked lower than
99.99% of the 596 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 16.61 vs. BSPM: 1.40 )
Ranked among companies with meaningful EV-to-EBITDA only.
BSPM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -9  Med: 1.4 Max: 21.5
Current: 1.4
-9
21.5
EV-to-Revenue 7.13
BSPM's EV-to-Revenue is ranked higher than
62% of the 775 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 3.07 vs. BSPM: 7.13 )
Ranked among companies with meaningful EV-to-Revenue only.
BSPM' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.1  Med: 0.5 Max: 22.7
Current: 7.13
-0.1
22.7
Shiller PE Ratio 1.67
BSPM's Shiller PE Ratio is ranked lower than
99.99% of the 204 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 36.18 vs. BSPM: 1.67 )
Ranked among companies with meaningful Shiller PE Ratio only.
BSPM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 1.02  Med: 1.23 Max: 1.8
Current: 1.67
1.02
1.8
Current Ratio 0.19
BSPM's Current Ratio is ranked lower than
83% of the 738 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.53 vs. BSPM: 0.19 )
Ranked among companies with meaningful Current Ratio only.
BSPM' s Current Ratio Range Over the Past 10 Years
Min: 0.17  Med: 4.44 Max: 19.49
Current: 0.19
0.17
19.49
Quick Ratio 0.16
BSPM's Quick Ratio is ranked lower than
70% of the 736 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.94 vs. BSPM: 0.16 )
Ranked among companies with meaningful Quick Ratio only.
BSPM' s Quick Ratio Range Over the Past 10 Years
Min: 0.14  Med: 4.39 Max: 19.17
Current: 0.16
0.14
19.17
Days Inventory 117.10
BSPM's Days Inventory is ranked higher than
78% of the 729 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 120.98 vs. BSPM: 117.10 )
Ranked among companies with meaningful Days Inventory only.
BSPM' s Days Inventory Range Over the Past 10 Years
Min: 6.29  Med: 10.84 Max: 117.1
Current: 117.1
6.29
117.1
Days Sales Outstanding 174.73
BSPM's Days Sales Outstanding is ranked lower than
100% of the 682 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 73.92 vs. BSPM: 174.73 )
Ranked among companies with meaningful Days Sales Outstanding only.
BSPM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 94.72  Med: 137.3 Max: 1032.07
Current: 174.73
94.72
1032.07

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -13.40
BSPM's 3-Year Average Share Buyback Ratio is ranked lower than
74% of the 522 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: -4.80 vs. BSPM: -13.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
BSPM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -18.1  Med: -11.7 Max: -8.5
Current: -13.4
-18.1
-8.5

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 0.16
BSPM's Price-to-Tangible-Book is ranked higher than
100% of the 735 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 3.49 vs. BSPM: 0.16 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
BSPM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.11  Med: 0.31 Max: 3.48
Current: 0.16
0.11
3.48
Price-to-Intrinsic-Value-Projected-FCF 0.08
BSPM's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
100% of the 306 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.32 vs. BSPM: 0.08 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
BSPM' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.05  Med: 0.12 Max: 0.28
Current: 0.08
0.05
0.28
Price-to-Median-PS-Value 36.40
BSPM's Price-to-Median-PS-Value is ranked lower than
97% of the 676 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.04 vs. BSPM: 36.40 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
BSPM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35  Med: 1.07 Max: 36.4
Current: 36.4
0.35
36.4
Price-to-Graham-Number 0.14
BSPM's Price-to-Graham-Number is ranked lower than
99.99% of the 438 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.97 vs. BSPM: 0.14 )
Ranked among companies with meaningful Price-to-Graham-Number only.
BSPM' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.1  Med: 0.46 Max: 1.47
Current: 0.14
0.1
1.47
Earnings Yield (Greenblatt) % 55.25
BSPM's Earnings Yield (Greenblatt) % is ranked lower than
97% of the 834 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 3.23 vs. BSPM: 55.25 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
BSPM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -33602.6  Med: 16.3 Max: 973548.4
Current: 55.25
-33602.6
973548.4

More Statistics

Revenue (TTM) (Mil) $0.96
EPS (TTM) $ 0.68
Beta0.36
Short Percentage of Float5.92%
52-Week Range $1.18 - 4.30
Shares Outstanding (Mil)2.64

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}